00983nas a2200301   4500000000100000000000100001008004100002653001500043653001400058653004000072653001700112653001500129653007800144653007900222653008600301653004000387100001200427700002800439700001500467700001500482700001500497700001500512245008600527250001500613300001400628490000700642020003200649       2023                            d10aCPRD Aurum10aCprd gold10aclinical practice research datalink10adata quality10aValidation10ashares of Amgen Inc. Jick, Vasilakis-Scaramozza, Persson, and Hagberg are10aemployees of Boston Collaborative Drug Surveillance program which receives10aindustry funding to conduct research using CPRD data. The authors report no other10aconflicts of interest in this work.1 aS. Jick1 aC. Vasilakis-Scaramozza1 aR. Persson1 aD. Neasham1 aG. Kafatos1 aK. Hagberg00aUse of the CPRD Aurum Database: Insights Gained from New Data Quality Assessments  a2023/12/21  a1219-12220 v15  a1179-1349 (Print)
1179-1349